Hiding in Plain Sight: The Opportunity to Dramatically Reduce Cigarette Smoking and Chronic Disease in America
to
Andrew Hyland, PhD
Division of Cancer Prevention and Population Sciences
Chair, Department of Health Behavior
The Robert, Ann and Lew Wallace Endowed Chair in Health Behavior
Roswell Park Comprehensive Cancer Center
Dr. Andrew Hyland has more than 25 years of experience doing tobacco control research. He has conducted numerous funded clinical and population-based studies, published more than 300 papers, and is widely recognized nationally and internationally for his expertise, including advisory roles for the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention, the National Cancer Institute and the International Agency for Research on Cancer. From 2006-2016, he served as the Deputy Editor for the scientific journal Tobacco Control, the leading international journal for tobacco control scientists.
As the Chair of the Department of Health Behavior at Roswell Park Comprehensive Cancer Center, he directs the New York State Smokers Quitline and has contracts with the New York State Department of Health to work with community and clinical stakeholders to advance their tobacco control work plan. He serves as the Scientific Leader of the Population Assessment of Tobacco and Health (PATH) study, which is supported by the National Institute on Drug Abuse (NIDA) and the Food and Drug Administration (FDA) to study more than 46,000 adults and children nationally over a 14-year period to understand changes in tobacco use behaviors and health. Dr. Hyland is a co-investigator for the International Tobacco Control Study, tracking cohorts of tobacco users in 29 countries to evaluate tobacco control policies.
Summary
Andrew Hyland from the Roswell Park Comprehensive Cancer Center in Buffalo, New York will describe cigarette use patterns over time, present research identifying cigarette smoking as a major contributor to chronic disease and describe factors increase our understanding why people smoke and what reduces cigarette smoking in the population. He will also highlight the PATH Study, a key component of the national data collection infrastructure, that has made significant scientific advances to understand the nature of tobacco use and its impacts. Lastly, he will also present information about how reduced levels of nicotine in cigarettes significantly reduce cigarette smoking and strategies that could result in wider adoption of this intervention in the population.
Presentation Objectives:
- To understand the epidemiology of cigarette smoking and its health impacts
- To understand factors that impact who smokes and population strategies that reduce cigarette smoking
- To understand the science and potential impact of a strategy that reduces the level of nicotine in cigarettes sold in the US
This page was last updated on Wednesday, September 17, 2025